Chlamydia and Gonorrhea

Ann Intern Med. 2021 Oct;174(10):ITC145-ITC160. doi: 10.7326/AITC202110190. Epub 2021 Oct 12.

Abstract

Gonorrhea and chlamydia rates have risen to record-high levels in the United States over the past decade. Because these infections are often asymptomatic, effective clinical management relies on screening of asymptomatic patients, particularly women younger than 25 years and men who have sex with men. If undetected and untreated, gonorrhea and chlamydia can lead to infertility, ectopic pregnancy, and chronic pelvic pain and can facilitate HIV acquisition and transmission. Primary care providers need to be aware of recent changes in recommended treatments for both infections.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Azithromycin / therapeutic use
  • Ceftriaxone / therapeutic use
  • Chlamydia Infections / diagnosis
  • Chlamydia Infections / drug therapy
  • Chlamydia Infections / epidemiology*
  • Doxycycline / therapeutic use
  • Female
  • Gentamicins / therapeutic use
  • Gonorrhea / diagnosis
  • Gonorrhea / drug therapy
  • Gonorrhea / epidemiology*
  • Humans
  • Male

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Ceftriaxone
  • Azithromycin
  • Doxycycline